Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection. (23rd August 2021)

• Record Type: Journal Article
• Authors: Ocher, Rebecca A.; Padilla, Erika; Hsu, Jonathan C.; Taub, Pam R.
• Other Names: Ercan Ertugurul Academic Editor.
• Is Part Of: Case reports in cardiology. Volume 2021(2021)
• Publication Date: 2021-08-23
• Subjects: Cardiology -- Periodicals; 616.12005
• DOI: 10.1155/2021/7809231
• Languages: English
• ISSNs: 2090-6404

Abstract

Abstract : A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors' knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients.